Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized acetazolamide trial in normal pressure hydrocephalus
2020-004132-22Phase 2Active
- Sponsor
- Akademiska sjukhuset
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Idiopathic Normal Pressure Hydrocephalus (NPH) and hydrocephalus comparing Acetazolamide with Placebo (2 arms). Primary endpoint: Primary gait performance composite. Started Nov 2020; status: active.
02
Drugs
acetazolamide
03
Conditions
Idiopathic Normal Pressure Hydrocephalus (NPH)hydrocephalus
Beyond the preview
Go deeper on 2020-004132-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004132-22.